Headline: Hypofractionated post-mastectomy radiation (PMRT) results in non-inferior rates of reconstruction complications.
The Study: There should be no lingering questions at this point that 42.56 Gy in 16 fractions is effective at controlling microscopic breast cancer. The flip side, of course, is toxicity. The primary organ at risk when delivering tangents to an intact breast is the breast tissue itself, where hypofractionation has proven to be—if anything—less toxic, often resulting in better cosmesis. Why? Because the (α/β) ratio of normal versus malignant breast tissue probably isn’t that different, with both being relatively low, so delivering a lower total dose is likely the most important way to reduce fibrosis. The legitimate concern with offering post-mastectomy hypofractionation is we’re less concerned with normal breast tissue than wound healing that requires healthy vascularization. While hypofractionation has proven safe for flat chest walls and implant-based reconstruction, there’s been a big question mark remaining for the popular autologous flap reconstruction. Enter RT CHARM, the largest most comprehensive trial of its kind where 898 women receiving PMRT in addition to breast reconstruction were randomized to conventional (50 Gy / 25) versus hypofractionated (42.56 Gy / 16) courses. Importantly, reconstruction was a catch all mirroring what we see in practice: it could be delayed (55%) or immediate (45%) and could be implant-alone (57%) or autologous-based (43%). The primary endpoint of reconstructive complications at 2 years was 12% (47/403) with conventional versus 14% (59/422) with hypofractionation easily meeting the predefined non-inferiority threshold. What did affect the complication rate? You guessed it: autologous had half the complication rate as implant-only reconstruction. A single-stage reconstruction was also beneficial whether upfront or delayed. This all strongly supports the growing evidence that using your own tissue without multiple stages of procedures (i.e. prolonged tissue expansions) leads to less operative complications. But don’t take our word for it. Listen to our interview with Dr. Poppe himself on the QuadCast podcast.
TBL: PMRT delivered in 16 fractions can now be considered a standard treatment option for women regardless of their plans for reconstruction, and single-stage autologous reconstructive techniques are much more likely to appreciably lower complication rates than fractionation schemes. | Poppe, ASTRO 2024
The Study: There should be no lingering questions at this point that 42.56 Gy in 16 fractions is effective at controlling microscopic breast cancer. The flip side, of course, is toxicity. The primary organ at risk when delivering tangents to an intact breast is the breast tissue itself, where hypofractionation has proven to be—if anything—less toxic, often resulting in better cosmesis. Why? Because the (α/β) ratio of normal versus malignant breast tissue probably isn’t that different, with both being relatively low, so delivering a lower total dose is likely the most important way to reduce fibrosis. The legitimate concern with offering post-mastectomy hypofractionation is we’re less concerned with normal breast tissue than wound healing that requires healthy vascularization. While hypofractionation has proven safe for flat chest walls and implant-based reconstruction, there’s been a big question mark remaining for the popular autologous flap reconstruction. Enter RT CHARM, the largest most comprehensive trial of its kind where 898 women receiving PMRT in addition to breast reconstruction were randomized to conventional (50 Gy / 25) versus hypofractionated (42.56 Gy / 16) courses. Importantly, reconstruction was a catch all mirroring what we see in practice: it could be delayed (55%) or immediate (45%) and could be implant-alone (57%) or autologous-based (43%). The primary endpoint of reconstructive complications at 2 years was 12% (47/403) with conventional versus 14% (59/422) with hypofractionation easily meeting the predefined non-inferiority threshold. What did affect the complication rate? You guessed it: autologous had half the complication rate as implant-only reconstruction. A single-stage reconstruction was also beneficial whether upfront or delayed. This all strongly supports the growing evidence that using your own tissue without multiple stages of procedures (i.e. prolonged tissue expansions) leads to less operative complications. But don’t take our word for it. Listen to our interview with Dr. Poppe himself on the QuadCast podcast.
TBL: PMRT delivered in 16 fractions can now be considered a standard treatment option for women regardless of their plans for reconstruction, and single-stage autologous reconstructive techniques are much more likely to appreciably lower complication rates than fractionation schemes. | Poppe, ASTRO 2024

